Based on all data discussed above it seems that PIK3CA mutation alone may not be an optimal genetic alteration to stratify ILC patients into better and worse prognostic group but rather an integration of several concurrent genetic alterations might outperform PIK3CA mutation in an individual tumor. This evidence concerns the gene PIK3CA and neoplasm.